Nicholas Simon - Insider Trading Tracker

TetraLogic Pharmaceuticals Corporation

US ˙ OTCPK

Pengenalan

Halaman ini menyediakan analisis menyeluruh tentang sejarah dagangan orang dalam yang diketahui Nicholas Simon. Orang dalam ialah pegawai, pengarah atau pelabur penting dalam syarikat. Adalah haram bagi orang dalam untuk membuat perdagangan dalam syarikat mereka berdasarkan maklumat khusus bukan awam. Ini tidak bermakna haram bagi mereka untuk membuat sebarang perdagangan dalam syarikat mereka sendiri. Tetapi mereka mesti melaporkan semua perdagangan kepada SEC melalui Borang 4. Walaupun terdapat sekatan ini, penyelidikan akademik menunjukkan bahawa orang dalam - secara amnya - cenderung untuk mengatasi prestasi pasaran dalam syarikat mereka sendiri.

Purata Keuntungan Perdagangan

Purata keuntungan perdagangan ialah purata pulangan semua pembelian pasaran terbuka yang dibuat oleh orang dalam dalam tempoh tiga tahun terakhir. Untuk mengira ini, kami memeriksa setiap pembelian pasaran terbuka yang tidak dirancang oleh orang dalam, tidak termasuk semua dagangan yang ditandakan sebagai sebahagian daripada pelan dagangan 10b5-1. Kami kemudian mengira prestasi purata dagangan tersebut sepanjang 3, 6 dan 12 bulan, dengan purata setiap tempoh tersebut untuk menjana metrik prestasi akhir bagi setiap dagangan. Akhir sekali, kami puratakan semua metrik prestasi untuk mengira metrik prestasi untuk orang dalam. Senarai ini hanya termasuk orang dalam yang telah membuat sekurang-kurangnya tiga dagangan dalam dua tahun lepas.

Jika keuntungan berdagang orang dalam ini ialah "N/A", maka orang dalam sama ada tidak membuat sebarang pembelian pasaran terbuka dalam tempoh tiga tahun terakhir, atau dagangan yang mereka buat adalah terlalu baru untuk mengira metrik prestasi yang boleh dipercayai.

Kekerapan Kemas Kini: Harian

Lihat senarai pedagang dalaman yang paling menguntungkan.

Lihat Orang Dalam Dengan Kedudukan Tertinggi

Syarikat dengan Kedudukan Orang Dalam yang Dilaporkan

Pemfailan SEC menunjukkan Nicholas Simon telah melaporkan pegangan atau perdagangan dalam syarikat berikut:

Sekuriti	Tajuk	Pegangan Terkini Dilaporkan
US:SIEN / Sientra, Inc.	Director	101,569
US:GRTS / Gritstone bio, Inc.	Director, 10% Owner	12,500
US:ETTX / Entasis Therapeutics Holdings Inc	10% Owner	0
US:FTSV / Forty Seven, Inc.	10% Owner	0
US:HAIR / Restoration Robotics, Inc.	10% Owner	0
US:TLOG / TetraLogic Pharmaceuticals Corporation	10% Owner	2,214,523
	10% Owner	2,237,377
US:OPHT / Ophthotech Corp	10% Owner	0
US:AERI / Aerie Pharmaceuticals Inc	10% Owner	0
US:GMED / Globus Medical, Inc.		0
	Director	22,078
US:ZGNX / Zogenix Inc	10% Owner	9,482,439
US:AVNR / Avanir Pharmaceuticals Inc	10% Owner	12

Bagaimana Mentafsir Carta

Carta berikut menunjukkan prestasi saham sekuriti selepas setiap dagangan pasaran terbuka dan tidak dirancang yang dibuat oleh Nicholas Simon. Perdagangan tidak dirancang ialah dagangan yang tidak dibuat sebagai sebahagian daripada pelan dagangan 10b5-1. Prestasi saham dicatatkan sebagai perubahan peratus kumulatif dalam harga saham. Sebagai contoh, jika perdagangan orang dalam dibuat pada 1 Januari 2019, carta akan menunjukkan perubahan peratusan harian sekuriti kepada hari ini. Jika harga saham naik dari $10 kepada $15 pada masa ini, perubahan peratus terkumpul dalam harga saham ialah 50%. Perubahan dalam harga daripada $10 kepada $20 ialah 100% dan perubahan dalam harga $10 hingga $5 ialah -50%.

Secara dasarnya, kami cuba untuk menentukan sejauh mana dagangan orang dalam berkait rapat dengan pulangan berlebihan (positif atau negatif) dalam harga saham untuk melihat sama ada orang dalam menetapkan masa dagangan mereka untuk mendapat keuntungan daripada maklumat orang dalam. Pertimbangkan situasi di mana orang dalam melakukan perkara ini. Dalam keadaan ini, kami menjangkakan sama ada (a) pulangan positif selepas pembelian, atau (b) pulangan negatif selepas jualan. Dalam kes (a), carta PEMBELIAN akan menunjukkan satu siri keluk condong ke atas, menunjukkan pulangan positif selepas setiap transaksi pembelian. Dalam kes (b), carta JUALAN akan menunjukkan satu siri keluk condong ke bawah, menunjukkan pulangan negatif selepas setiap transaksi jualan.

Walau bagaimanapun, ini sahaja tidak cukup untuk membuat kesimpulan. Jika, sebagai contoh, harga saham syarikat berada dalam pendakian bukan disebabkan kitaran selama bertahun-tahun, maka kami menjangkakan semua plot selepas pembelian akan condong ke atas. Begitu juga, kemerosotan bukan disebabkan kitaran selama bertahun-tahun akan mengakibatkan plot pasca perdagangan condong ke bawah. Kedua-dua carta ini tidak akan mencadangkan aktiviti perdagangan orang dalam.

Penunjuk terkuat ialah keadaan di mana harga saham adalah sangat kitaran, dan terdapat kedua-dua isyarat positif dalam carta PEMBELIAN dan plot negatif pada carta JUALAN. Situasi ini akan sangat menunjukkan orang dalam yang menentukan masa perdagangan untuk kelebihan kewangan mereka.

Pembelian Orang Dalam TLOG / TetraLogic Pharmaceuticals Corporation - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam TLOG / TetraLogic Pharmaceuticals Corporation. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan	Simbol Saham	Orang dalam	Saham Dilaporkan	Harga Dilaporkan	Saham Dilaraskan	Harga Dilaraskan	Asas Kos	Hari ke Maks	Harga pada Maks	Maks Keuntungan ($)	Pulangan Maks (%)
2013-12-17	TLOG	Clarus Lifesciences II, L.P.	1,425,063	7.0000	1,425,063	7.0000	9,975,441	31	12.25	7,481,581	75.00

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam TLOG / TetraLogic Pharmaceuticals Corporation - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam TLOG / TetraLogic Pharmaceuticals Corporation. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

2016-02-09 TLOG Clarus Lifesciences II, L.P. 230,507 0.1600 230,507 0.1600 36,881 317 0.0301 -29,943 -81.19

2016-02-08 TLOG Clarus Lifesciences II, L.P. 103,123 0.1900 103,123 0.1900 19,593

2016-02-05 TLOG Clarus Lifesciences II, L.P. 832,881 0.2000 832,881 0.2000 166,576

2016-02-04 TLOG Clarus Lifesciences II, L.P. 500,026 0.1400 500,026 0.1400 70,004

2016-02-03 TLOG Clarus Lifesciences II, L.P. 82,583 0.1500 82,583 0.1500 12,387

2016-02-02 TLOG Clarus Lifesciences II, L.P. 176,306 0.1700 176,306 0.1700 29,972

2016-02-01 TLOG Clarus Lifesciences II, L.P. 140,000 0.2000 140,000 0.2000 28,000

2016-01-29 TLOG Clarus Lifesciences II, L.P. 52,826 0.2600 52,826 0.2600 13,735

2016-01-28 TLOG Clarus Lifesciences II, L.P. 32,521 0.2600 32,521 0.2600 8,455

2016-01-27 TLOG Clarus Lifesciences II, L.P. 209,984 0.2700 209,984 0.2700 56,696

2016-01-26 TLOG Clarus Lifesciences II, L.P. 69,425 0.3000 69,425 0.3000 20,828

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Pembelian Orang Dalam VERO / Venus Concept Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam TLOG / TetraLogic Pharmaceuticals Corporation. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Maks Harga pada
Maks Maks
Keuntungan ($) Pulangan Maks (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam VERO / Venus Concept Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam TLOG / TetraLogic Pharmaceuticals Corporation. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Sejarah Dagangan Orang Dalam

Jadual ini menunjukkan senarai lengkap dagangan orang dalam yang dibuat oleh Nicholas Simon seperti yang didedahkan kepada Suruhanjaya Bursa Sekuriti (SEC).

Tarikh Fail Tarikh Tran Borang Simbol Saham Sekuriti Kod 10b5-1 Saham Baki Saham Peratus
Ubah Saham
harga Tran
Nilai Baki
Nilai

2021-06-15 2021-06-10 4 SIEN Sientra, Inc.
Common Stock A - Award 16,870 101,569 19.92

2020-06-22 2020-06-18 4 GRTS Gritstone Oncology, Inc.
Stock Option (Right to Buy) A - Award 12,500 12,500

2020-06-09 2020-06-05 4 SIEN Sientra, Inc.
Common Stock (RSUs) A - Award 27,717 84,699 48.64

2019-06-20 2019-06-19 4 GRTS Gritstone Oncology, Inc.
Stock Option (Right to Buy) A - Award 8,570 8,570

2019-06-18 2019-06-14 4 SIEN Sientra, Inc.
Common Stock (RSUs) A - Award 19,320 56,982 51.30

2018-10-02 2018-10-02 4 GRTS Gritstone Oncology, Inc.
Series B Convertible Preferred Stock C - Conversion -668,896 0 -100.00

2018-10-02 2018-10-02 4 GRTS Gritstone Oncology, Inc.
Series A Convertible Preferred Stock C - Conversion -1,565,216 0 -100.00

2018-10-02 2018-10-02 4 GRTS Gritstone Oncology, Inc.
Common Stock C - Conversion 2,234,112 2,567,445 670.23

2018-10-02 2018-09-28 4 GRTS Gritstone Oncology, Inc.
Common Stock P - Purchase 333,333 333,333 15.00 4,999,995 4,999,995

2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Series B-1 Tranche B Convertible Preferred Stock C - Conversion -8,552,024 0 -100.00

2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Series B-1 Tranche A Convertible Preferred Stock C - Conversion -6,702,213 0 -100.00

2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Series B Convertible Preferred Stock C - Conversion -7,500,000 0 -100.00

2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Common Stock P - Purchase 453,395 1,623,405 38.75 15.00 6,800,925 24,351,075

2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Common Stock C - Conversion 412,583 1,170,010 54.47

2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Common Stock C - Conversion 323,341 685,170 89.36

2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Common Stock C - Conversion 361,829 361,829

2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Series B Preferred Stock C - Conversion -1,922,682 0 -100.00

2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Series A-2 Preferred Stock C - Conversion -755,780 0 -100.00

2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Series A-1 Preferred Stock C - Conversion -938,489 0 -100.00

2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Common Stock P - Purchase 200,000 3,816,951 5.53 16.00 3,200,000 61,071,216

2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Common Stock C - Conversion 1,922,682 3,616,951 113.48

2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Common Stock C - Conversion 755,780 1,694,269 80.53

2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Common Stock C - Conversion 938,489 938,489

2018-06-07 2018-06-05 4 SIEN Sientra, Inc.
Common Stock (RSUs) A - Award 6,116 37,662 19.39 20.44 125,011 769,811

2017-10-17 2017-10-16 4 HAIR Restoration Robotics Inc
Series C Preferred Stock C - Conversion -3,389,105 0 -100.00

2017-10-17 2017-10-16 4 HAIR Restoration Robotics Inc
Convertible Promissory Note C - Conversion 0

2017-10-17 2017-10-16 4 HAIR Restoration Robotics Inc
Common Stock C - Conversion 180,881 3,569,986 5.34 7.00 1,266,167 24,989,902

2017-10-17 2017-10-16 4 HAIR Restoration Robotics Inc
Common Stock C - Conversion 3,389,105 3,389,105

2017-10-13 2017-10-11 4 HAIR Restoration Robotics Inc
Convertible Promissory Note J - Other 1,259,269.79

2017-06-26 2017-06-22 4 SIEN Sientra, Inc.
Common Stock A - Award 12,861 31,546 68.83 9.72 125,009 306,627

2016-06-27 2016-06-23 4 SIEN Sientra, Inc.
Common Stock A - Award 18,685 18,685 6.69 125,003 125,003

2016-02-10 2016-02-09 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock S - Sale -230,507 2,214,523 -9.43 0.16 -36,881 354,324

2016-02-10 2016-02-08 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock S - Sale -103,123 2,445,030 -4.05 0.19 -19,593 464,556

2016-02-05 2016-02-05 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock S - Sale -832,881 2,548,153 -24.63 0.20 -166,576 509,631

2016-02-05 2016-02-04 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock S - Sale -500,026 3,381,034 -12.88 0.14 -70,004 473,345

2016-02-05 2016-02-03 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock S - Sale -82,583 3,881,060 -2.08 0.15 -12,387 582,159

2016-02-02 2016-02-02 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock S - Sale -176,306 3,963,643 -4.26 0.17 -29,972 673,819

2016-02-02 2016-02-01 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock S - Sale -140,000 4,139,949 -3.27 0.20 -28,000 827,990

2016-02-02 2016-01-29 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock S - Sale -52,826 4,279,949 -1.22 0.26 -13,735 1,112,787

2016-01-28 2016-01-28 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock S - Sale -32,521 4,332,775 -0.74 0.26 -8,455 1,126,522

2016-01-28 2016-01-27 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock S - Sale -209,984 4,365,296 -4.59 0.27 -56,696 1,178,630

2016-01-28 2016-01-26 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock S - Sale -69,425 4,575,280 -1.49 0.30 -20,828 1,372,584

2015-08-17 2015-06-26 4 SIEN Sientra, Inc.
Stock Option (right to buy) A - Award 7,037 7,037

2015-06-17 2015-06-16 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -39,701 2,237,377 -1.74 14.30 -567,724 31,994,491

2015-06-17 2015-06-15 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -1,529 2,277,078 -0.07 14.27 -21,819 32,493,903

2015-06-12 2015-06-12 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -6,430 2,278,607 -0.28 14.25 -91,628 32,470,150

2015-06-12 2015-06-11 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -25,168 2,285,037 -1.09 14.27 -359,147 32,607,478

2015-06-10 2015-06-10 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -8,987 2,310,205 -0.39 14.32 -128,694 33,082,136

2015-06-10 2015-06-09 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -13,000 2,319,192 -0.56 14.26 -185,380 33,071,678

2015-06-10 2015-06-08 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -2,662 2,332,192 -0.11 14.25 -37,934 33,233,736

2015-06-03 2015-06-03 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -10,450 2,334,854 -0.45 14.32 -149,644 33,435,109

2015-06-03 2015-06-02 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -11,014 2,345,304 -0.47 14.25 -156,950 33,420,582

2015-06-03 2015-06-01 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -15,010 2,356,318 -0.63 14.29 -214,493 33,671,784

2015-05-28 2015-05-26 4 OPHT Ophthotech Corp.
Common Stock J - Other -1,554,744 0 -100.00

2015-03-24 2015-03-23 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -26,300 2,371,328 -1.10 14.44 -379,772 34,241,976

2015-03-24 2015-03-20 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -27,115 2,397,628 -1.12 14.53 -393,981 34,837,535

2015-03-19 2015-03-19 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -50,012 2,424,743 -2.02 14.61 -730,675 35,425,495

2015-03-19 2015-03-18 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -25,000 2,474,755 -1.00 14.68 -367,000 36,329,403

2015-03-19 2015-03-17 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -79,307 2,499,755 -3.08 14.67 -1,163,434 36,671,406

2015-01-30 2015-01-28 4 AERI AERIE PHARMACEUTICALS INC
Common Stock J - Other -3,139,447 0 -100.00

2015-01-30 2013-10-25 4/A AERI AERIE PHARMACEUTICALS INC
Common Stock Warrant C - Conversion 184,812 0 -100.00

2015-01-30 2013-10-25 4/A AERI AERIE PHARMACEUTICALS INC
Series B Preferred Warrant C - Conversion -184,812 0 -100.00

2015-01-30 2013-10-25 4/A AERI AERIE PHARMACEUTICALS INC
Common Stock P - Purchase 321,000 3,468,494 10.20 10.00 3,210,000 34,684,940

2015-01-12 2015-01-08 4 AERI AERIE PHARMACEUTICALS INC
Common Stock S - Sale -175,000 3,324,259 -5.00 31.11 -5,444,250 103,417,697

2015-01-06 2015-01-05 4 AERI AERIE PHARMACEUTICALS INC
Common Stock S - Sale -10,200 3,499,259 -0.29 31.11 -317,322 108,861,947

2015-01-06 2015-01-05 4 AERI AERIE PHARMACEUTICALS INC
Common Stock S - Sale -13,420 3,509,459 -0.38 30.67 -411,591 107,635,108

2014-12-30 2014-12-29 4 AERI AERIE PHARMACEUTICALS INC
Common Stock S - Sale -6,214 3,522,879 -0.18 30.03 -186,606 105,792,056

2014-12-30 2014-12-26 4 AERI AERIE PHARMACEUTICALS INC
Common Stock S - Sale -74,510 3,529,093 -2.07 30.05 -2,239,026 106,049,245

2014-12-24 2014-12-23 4 AERI AERIE PHARMACEUTICALS INC
Common Stock S - Sale -263 3,603,603 -0.01 30.00 -7,890 108,108,090

2014-12-24 2014-12-22 4 AERI AERIE PHARMACEUTICALS INC
Common Stock S - Sale -49,441 3,603,866 -1.35 30.36 -1,501,029 109,413,372

2014-10-28 3 SIEN Sientra, Inc.
Common Stock 5,461,530

2014-10-28 3 SIEN Sientra, Inc.
Common Stock 5,461,530

2014-06-16 2014-06-11 4 AERI AERIE PHARMACEUTICALS INC
Option (right to buy) A - Award 13,500 13,500

2014-06-11 2014-06-11 4 OPHT Ophthotech Corp.
Common Stock S - Sale -500 4,500 -10.00 44.32 -22,160 199,440

2014-06-11 2014-06-11 4 OPHT Ophthotech Corp.
Common Stock S - Sale -29,217 2,843,564 -1.02 44.53 -1,301,074 126,627,886

2014-06-11 2014-06-10 4 OPHT Ophthotech Corp.
Common Stock S - Sale -200 2,872,781 -0.01 46.80 -9,360 134,446,151

2014-06-11 2014-06-10 4 OPHT Ophthotech Corp.
Common Stock S - Sale -36,880 2,872,981 -1.27 45.90 -1,692,630 131,857,187

2014-06-11 2014-06-10 4 OPHT Ophthotech Corp.
Common Stock S - Sale -79,824 2,909,861 -2.67 44.66 -3,564,988 129,956,138

2014-06-11 2014-06-09 4 OPHT Ophthotech Corp.
Common Stock S - Sale -39,362 2,989,685 -1.30 46.78 -1,841,500 139,868,526

2014-06-11 2014-06-09 4 OPHT Ophthotech Corp.
Common Stock S - Sale -25,697 3,029,047 -0.84 46.02 -1,182,463 139,383,415

2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Warrants X - Other -23,282 0 -100.00 6.40 -149,056

2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Convertible Notes C - Conversion -853,416 0 -100.00

2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Series C Convertible Preferred Stock C - Conversion -2,342,944 0 -100.00

2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock X - Other 23,282 4,644,705 0.50 6.40 149,056 29,736,330

2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock C - Conversion 853,416 4,621,423 22.65 7.00 5,973,912 32,349,961

2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock C - Conversion 2,342,944 3,768,007 164.41

2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock P - Purchase 1,425,063 1,425,063 7.00 9,975,441 9,975,441

2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Series G Preferred Ordinary Shares C - Conversion -203,439 0 -100.00

2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Series F Preferred Ordinary Shares C - Conversion -553,859 0 -100.00

2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Series E Preferred Ordinary Shares C - Conversion -1,239,308 0 -100.00

2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares C - Conversion -582,456 0 -100.00

2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares C - Conversion 203,439 2,579,062 8.56

2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares C - Conversion 553,859 2,375,623 30.40

2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares C - Conversion 1,239,308 1,821,764 212.77

2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares C - Conversion 582,456 582,456

2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Convertible Notes C - Conversion -420,222 0 -100.00

2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Series B Warrants C - Conversion -184,812 0 -100.00

2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Series B Convertible Preferred Stock C - Conversion -2,727,272 0 -100.00

2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Common Stock P - Purchase 321,000 3,653,306 9.63 10.00 3,210,000 36,533,060

2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Common Stock C - Conversion 184,812 3,332,306 5.87 0.05 9,241 166,615

2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Common Stock C - Conversion 420,222 3,147,494 15.41

2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Common Stock C - Conversion 2,727,272 2,727,272

2013-10-02 2013-09-30 4 OPHT Ophthotech Corp.
Series C Preferred Stock C - Conversion -186,027 0 -100.00

2013-10-02 2013-09-30 4 OPHT Ophthotech Corp.
Series B Preferred Stock C - Conversion -2,542,373 0 -100.00

2013-10-02 2013-09-30 4 OPHT Ophthotech Corp.
Common Stock C - Conversion 186,027 2,728,390 7.32

2013-10-02 2013-09-30 4 OPHT Ophthotech Corp.
Common Stock C - Conversion 2,542,373 2,542,373

2013-09-04 2013-09-03 4 GMED GLOBUS MEDICAL INC
Class A Common Stock J - Other -7,244,201 0 -100.00

2012-08-10 2012-08-08 4 GMED GLOBUS MEDICAL INC
Series E Preferred Stock C - Conversion -7,444,168 0 -100.00

2012-08-10 2012-08-08 4 GMED GLOBUS MEDICAL INC
Class A Common Stock S - Sale -804,232 7,244,201 -9.99 11.16 -8,975,229 80,845,283

2012-08-10 2012-08-08 4 GMED GLOBUS MEDICAL INC
Class A Common Stock C - Conversion 7,444,168 8,048,433 1,231.94

2012-08-02 3 GMED GLOBUS MEDICAL INC
Class A Common Stock 604,265

2012-06-06 2012-06-04 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock J - Other 22,078 22,078

2012-06-06 2012-06-04 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock J - Other 51,515 51,515

2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock Warrant (right to buy) X - Other -1,290,922 0 -100.00

2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock Warrant (right to buy) X - Other -1,706,426 0 -100.00

2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock S - Sale -708,810 10,942,471 -6.08 7.49 -5,311,255 81,994,124

2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock S - Sale -608,146 11,651,281 -4.96 7.49 -4,556,960 87,305,379

2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock X - Other 1,706,426 12,259,427 16.17 3.11 5,311,251 38,157,467

2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock X - Other 1,290,922 10,553,001 13.94 3.53 4,556,955 37,252,094

2011-09-20 2011-09-16 4 ZGNX ZOGENIX, INC.
Common Stock P - Purchase 3,500,000 9,482,439 58.50 2.00 7,000,000 18,964,878

2010-12-07 2010-12-03 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock J - Other -6,669,204 12 -100.00

2010-11-10 2010-11-09 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock S - Sale -1,200,000 6,669,216 -15.25 4.81 -5,773,920 32,089,600

2010-11-10 2010-11-08 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock S - Sale -44,626 7,869,216 -0.56 5.10 -227,593 40,133,002

2010-11-05 2010-11-05 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock S - Sale -332,572 7,913,842 -4.03 4.80 -1,597,377 38,010,975

2010-11-05 2010-11-03 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock S - Sale -1,400,106 8,246,414 -14.51 4.52 -6,332,539 37,297,706

2010-11-02 2010-11-02 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock S - Sale -1,290,871 9,646,520 -11.80 4.49 -5,800,400 43,345,673

2010-11-02 2010-11-01 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock S - Sale -2,478,142 10,937,391 -18.47 5.36 -13,273,424 58,582,854

2010-11-02 2010-10-29 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock S - Sale -1,424,947 13,415,533 -9.60 5.06 -7,215,647 67,933,576

2010-10-12 2010-10-11 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock S - Sale -311,000 14,840,480 -2.05 3.52 -1,093,445 52,177,644

2010-10-12 2010-10-08 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock S - Sale -240,838 15,151,480 -1.56 3.47 -836,792 52,643,817

2010-07-15 2010-07-13 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock S - Sale -165,000 15,392,318 -1.06 3.53 -583,143 54,399,530

2008-04-11 3 AVNR AVANIR PHARMACEUTICALS
Class A Common Stock 15,557,318

P

Pasaran terbuka atau pembelian persendirian sekuriti bukan derivatif atau derivatif

S

Pasaran terbuka atau jualan persendirian sekuriti bukan derivatif atau derivatif

A

Pemberian, penganugerahan atau pemerolehan lain sekuriti daripada syarikat (seperti opsyen)

C

Penukaran derivatif

D

Penjualan atau pemindahan sekuriti kembali kepada syarikat

F

Pembayaran harga pelaksanaan atau liabiliti cukai menggunakan sebahagian daripada sekuriti yang diterima daripada syarikat

G

Hadiah sekuriti oleh atau kepada orang dalam

K

Swap ekuiti dan urus niaga lindung nilai yang serupa

M

Pelaksanaan atau penukaran sekuriti derivatif yang diterima daripada syarikat (seperti opsyen)

V

Transaksi dilaporkan secara sukarela pada Borang 4

J

Lain-lain (disertai dengan nota kaki yang menerangkan transaksi)

Tarikh Dagangan	Simbol Saham	Orang dalam	Saham Dilaporkan	Harga Dilaporkan	Saham Dilaraskan	Harga Dilaraskan	Asas Kos	Hari ke Min	Harga pada Min	Kerugian Maks Dielakkan ($)	Kerugian Maks Dielakkan (%)
2016-02-09	TLOG	Clarus Lifesciences II, L.P.	230,507	0.1600	230,507	0.1600	36,881	317	0.0301	-29,943	-81.19
2016-02-08	TLOG	Clarus Lifesciences II, L.P.	103,123	0.1900	103,123	0.1900	19,593
2016-02-05	TLOG	Clarus Lifesciences II, L.P.	832,881	0.2000	832,881	0.2000	166,576
2016-02-04	TLOG	Clarus Lifesciences II, L.P.	500,026	0.1400	500,026	0.1400	70,004
2016-02-03	TLOG	Clarus Lifesciences II, L.P.	82,583	0.1500	82,583	0.1500	12,387
2016-02-02	TLOG	Clarus Lifesciences II, L.P.	176,306	0.1700	176,306	0.1700	29,972
2016-02-01	TLOG	Clarus Lifesciences II, L.P.	140,000	0.2000	140,000	0.2000	28,000
2016-01-29	TLOG	Clarus Lifesciences II, L.P.	52,826	0.2600	52,826	0.2600	13,735
2016-01-28	TLOG	Clarus Lifesciences II, L.P.	32,521	0.2600	32,521	0.2600	8,455
2016-01-27	TLOG	Clarus Lifesciences II, L.P.	209,984	0.2700	209,984	0.2700	56,696
2016-01-26	TLOG	Clarus Lifesciences II, L.P.	69,425	0.3000	69,425	0.3000	20,828

Tarikh Fail	Tarikh Tran	Borang	Simbol Saham	Sekuriti	Kod	Saham	Baki Saham	Peratus Ubah	Saham harga	Tran Nilai	Baki Nilai
2021-06-15	2021-06-10	4	SIEN	Sientra, Inc. Common Stock	A - Award	16,870	101,569	19.92
2020-06-22	2020-06-18	4	GRTS	Gritstone Oncology, Inc. Stock Option (Right to Buy)	A - Award	12,500	12,500
2020-06-09	2020-06-05	4	SIEN	Sientra, Inc. Common Stock (RSUs)	A - Award	27,717	84,699	48.64
2019-06-20	2019-06-19	4	GRTS	Gritstone Oncology, Inc. Stock Option (Right to Buy)	A - Award	8,570	8,570
2019-06-18	2019-06-14	4	SIEN	Sientra, Inc. Common Stock (RSUs)	A - Award	19,320	56,982	51.30
2018-10-02	2018-10-02	4	GRTS	Gritstone Oncology, Inc. Series B Convertible Preferred Stock	C - Conversion	-668,896	0	-100.00
2018-10-02	2018-10-02	4	GRTS	Gritstone Oncology, Inc. Series A Convertible Preferred Stock	C - Conversion	-1,565,216	0	-100.00
2018-10-02	2018-10-02	4	GRTS	Gritstone Oncology, Inc. Common Stock	C - Conversion	2,234,112	2,567,445	670.23
2018-10-02	2018-09-28	4	GRTS	Gritstone Oncology, Inc. Common Stock	P - Purchase	333,333	333,333		15.00	4,999,995	4,999,995
2018-10-02	2018-09-28	4	ETTX	Entasis Therapeutics Holdings Inc. Series B-1 Tranche B Convertible Preferred Stock	C - Conversion	-8,552,024	0	-100.00
2018-10-02	2018-09-28	4	ETTX	Entasis Therapeutics Holdings Inc. Series B-1 Tranche A Convertible Preferred Stock	C - Conversion	-6,702,213	0	-100.00
2018-10-02	2018-09-28	4	ETTX	Entasis Therapeutics Holdings Inc. Series B Convertible Preferred Stock	C - Conversion	-7,500,000	0	-100.00
2018-10-02	2018-09-28	4	ETTX	Entasis Therapeutics Holdings Inc. Common Stock	P - Purchase	453,395	1,623,405	38.75	15.00	6,800,925	24,351,075
2018-10-02	2018-09-28	4	ETTX	Entasis Therapeutics Holdings Inc. Common Stock	C - Conversion	412,583	1,170,010	54.47
2018-10-02	2018-09-28	4	ETTX	Entasis Therapeutics Holdings Inc. Common Stock	C - Conversion	323,341	685,170	89.36
2018-10-02	2018-09-28	4	ETTX	Entasis Therapeutics Holdings Inc. Common Stock	C - Conversion	361,829	361,829
2018-07-02	2018-07-02	4	FTSV	Forty Seven, Inc. Series B Preferred Stock	C - Conversion	-1,922,682	0	-100.00
2018-07-02	2018-07-02	4	FTSV	Forty Seven, Inc. Series A-2 Preferred Stock	C - Conversion	-755,780	0	-100.00
2018-07-02	2018-07-02	4	FTSV	Forty Seven, Inc. Series A-1 Preferred Stock	C - Conversion	-938,489	0	-100.00
2018-07-02	2018-07-02	4	FTSV	Forty Seven, Inc. Common Stock	P - Purchase	200,000	3,816,951	5.53	16.00	3,200,000	61,071,216
2018-07-02	2018-07-02	4	FTSV	Forty Seven, Inc. Common Stock	C - Conversion	1,922,682	3,616,951	113.48
2018-07-02	2018-07-02	4	FTSV	Forty Seven, Inc. Common Stock	C - Conversion	755,780	1,694,269	80.53
2018-07-02	2018-07-02	4	FTSV	Forty Seven, Inc. Common Stock	C - Conversion	938,489	938,489
2018-06-07	2018-06-05	4	SIEN	Sientra, Inc. Common Stock (RSUs)	A - Award	6,116	37,662	19.39	20.44	125,011	769,811
2017-10-17	2017-10-16	4	HAIR	Restoration Robotics Inc Series C Preferred Stock	C - Conversion	-3,389,105	0	-100.00
2017-10-17	2017-10-16	4	HAIR	Restoration Robotics Inc Convertible Promissory Note	C - Conversion		0
2017-10-17	2017-10-16	4	HAIR	Restoration Robotics Inc Common Stock	C - Conversion	180,881	3,569,986	5.34	7.00	1,266,167	24,989,902
2017-10-17	2017-10-16	4	HAIR	Restoration Robotics Inc Common Stock	C - Conversion	3,389,105	3,389,105
2017-10-13	2017-10-11	4	HAIR	Restoration Robotics Inc Convertible Promissory Note	J - Other				1,259,269.79
2017-06-26	2017-06-22	4	SIEN	Sientra, Inc. Common Stock	A - Award	12,861	31,546	68.83	9.72	125,009	306,627
2016-06-27	2016-06-23	4	SIEN	Sientra, Inc. Common Stock	A - Award	18,685	18,685		6.69	125,003	125,003
2016-02-10	2016-02-09	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	S - Sale	-230,507	2,214,523	-9.43	0.16	-36,881	354,324
2016-02-10	2016-02-08	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	S - Sale	-103,123	2,445,030	-4.05	0.19	-19,593	464,556
2016-02-05	2016-02-05	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	S - Sale	-832,881	2,548,153	-24.63	0.20	-166,576	509,631
2016-02-05	2016-02-04	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	S - Sale	-500,026	3,381,034	-12.88	0.14	-70,004	473,345
2016-02-05	2016-02-03	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	S - Sale	-82,583	3,881,060	-2.08	0.15	-12,387	582,159
2016-02-02	2016-02-02	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	S - Sale	-176,306	3,963,643	-4.26	0.17	-29,972	673,819
2016-02-02	2016-02-01	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	S - Sale	-140,000	4,139,949	-3.27	0.20	-28,000	827,990
2016-02-02	2016-01-29	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	S - Sale	-52,826	4,279,949	-1.22	0.26	-13,735	1,112,787
2016-01-28	2016-01-28	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	S - Sale	-32,521	4,332,775	-0.74	0.26	-8,455	1,126,522
2016-01-28	2016-01-27	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	S - Sale	-209,984	4,365,296	-4.59	0.27	-56,696	1,178,630
2016-01-28	2016-01-26	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	S - Sale	-69,425	4,575,280	-1.49	0.30	-20,828	1,372,584
2015-08-17	2015-06-26	4	SIEN	Sientra, Inc. Stock Option (right to buy)	A - Award	7,037	7,037
2015-06-17	2015-06-16	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-39,701	2,237,377	-1.74	14.30	-567,724	31,994,491
2015-06-17	2015-06-15	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-1,529	2,277,078	-0.07	14.27	-21,819	32,493,903
2015-06-12	2015-06-12	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-6,430	2,278,607	-0.28	14.25	-91,628	32,470,150
2015-06-12	2015-06-11	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-25,168	2,285,037	-1.09	14.27	-359,147	32,607,478
2015-06-10	2015-06-10	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-8,987	2,310,205	-0.39	14.32	-128,694	33,082,136
2015-06-10	2015-06-09	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-13,000	2,319,192	-0.56	14.26	-185,380	33,071,678
2015-06-10	2015-06-08	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-2,662	2,332,192	-0.11	14.25	-37,934	33,233,736
2015-06-03	2015-06-03	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-10,450	2,334,854	-0.45	14.32	-149,644	33,435,109
2015-06-03	2015-06-02	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-11,014	2,345,304	-0.47	14.25	-156,950	33,420,582
2015-06-03	2015-06-01	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-15,010	2,356,318	-0.63	14.29	-214,493	33,671,784
2015-05-28	2015-05-26	4	OPHT	Ophthotech Corp. Common Stock	J - Other	-1,554,744	0	-100.00
2015-03-24	2015-03-23	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-26,300	2,371,328	-1.10	14.44	-379,772	34,241,976
2015-03-24	2015-03-20	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-27,115	2,397,628	-1.12	14.53	-393,981	34,837,535
2015-03-19	2015-03-19	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-50,012	2,424,743	-2.02	14.61	-730,675	35,425,495
2015-03-19	2015-03-18	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-25,000	2,474,755	-1.00	14.68	-367,000	36,329,403
2015-03-19	2015-03-17	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-79,307	2,499,755	-3.08	14.67	-1,163,434	36,671,406
2015-01-30	2015-01-28	4	AERI	AERIE PHARMACEUTICALS INC Common Stock	J - Other	-3,139,447	0	-100.00
2015-01-30	2013-10-25	4/A	AERI	AERIE PHARMACEUTICALS INC Common Stock Warrant	C - Conversion	184,812	0	-100.00
2015-01-30	2013-10-25	4/A	AERI	AERIE PHARMACEUTICALS INC Series B Preferred Warrant	C - Conversion	-184,812	0	-100.00
2015-01-30	2013-10-25	4/A	AERI	AERIE PHARMACEUTICALS INC Common Stock	P - Purchase	321,000	3,468,494	10.20	10.00	3,210,000	34,684,940
2015-01-12	2015-01-08	4	AERI	AERIE PHARMACEUTICALS INC Common Stock	S - Sale	-175,000	3,324,259	-5.00	31.11	-5,444,250	103,417,697
2015-01-06	2015-01-05	4	AERI	AERIE PHARMACEUTICALS INC Common Stock	S - Sale	-10,200	3,499,259	-0.29	31.11	-317,322	108,861,947
2015-01-06	2015-01-05	4	AERI	AERIE PHARMACEUTICALS INC Common Stock	S - Sale	-13,420	3,509,459	-0.38	30.67	-411,591	107,635,108
2014-12-30	2014-12-29	4	AERI	AERIE PHARMACEUTICALS INC Common Stock	S - Sale	-6,214	3,522,879	-0.18	30.03	-186,606	105,792,056
2014-12-30	2014-12-26	4	AERI	AERIE PHARMACEUTICALS INC Common Stock	S - Sale	-74,510	3,529,093	-2.07	30.05	-2,239,026	106,049,245
2014-12-24	2014-12-23	4	AERI	AERIE PHARMACEUTICALS INC Common Stock	S - Sale	-263	3,603,603	-0.01	30.00	-7,890	108,108,090
2014-12-24	2014-12-22	4	AERI	AERIE PHARMACEUTICALS INC Common Stock	S - Sale	-49,441	3,603,866	-1.35	30.36	-1,501,029	109,413,372
2014-10-28		3	SIEN	Sientra, Inc. Common Stock			5,461,530
2014-10-28		3	SIEN	Sientra, Inc. Common Stock			5,461,530
2014-06-16	2014-06-11	4	AERI	AERIE PHARMACEUTICALS INC Option (right to buy)	A - Award	13,500	13,500
2014-06-11	2014-06-11	4	OPHT	Ophthotech Corp. Common Stock	S - Sale	-500	4,500	-10.00	44.32	-22,160	199,440
2014-06-11	2014-06-11	4	OPHT	Ophthotech Corp. Common Stock	S - Sale	-29,217	2,843,564	-1.02	44.53	-1,301,074	126,627,886
2014-06-11	2014-06-10	4	OPHT	Ophthotech Corp. Common Stock	S - Sale	-200	2,872,781	-0.01	46.80	-9,360	134,446,151
2014-06-11	2014-06-10	4	OPHT	Ophthotech Corp. Common Stock	S - Sale	-36,880	2,872,981	-1.27	45.90	-1,692,630	131,857,187
2014-06-11	2014-06-10	4	OPHT	Ophthotech Corp. Common Stock	S - Sale	-79,824	2,909,861	-2.67	44.66	-3,564,988	129,956,138
2014-06-11	2014-06-09	4	OPHT	Ophthotech Corp. Common Stock	S - Sale	-39,362	2,989,685	-1.30	46.78	-1,841,500	139,868,526
2014-06-11	2014-06-09	4	OPHT	Ophthotech Corp. Common Stock	S - Sale	-25,697	3,029,047	-0.84	46.02	-1,182,463	139,383,415
2013-12-19	2013-12-17	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Warrants	X - Other	-23,282	0	-100.00	6.40	-149,056
2013-12-19	2013-12-17	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Convertible Notes	C - Conversion	-853,416	0	-100.00
2013-12-19	2013-12-17	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Series C Convertible Preferred Stock	C - Conversion	-2,342,944	0	-100.00
2013-12-19	2013-12-17	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	X - Other	23,282	4,644,705	0.50	6.40	149,056	29,736,330
2013-12-19	2013-12-17	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	C - Conversion	853,416	4,621,423	22.65	7.00	5,973,912	32,349,961
2013-12-19	2013-12-17	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	C - Conversion	2,342,944	3,768,007	164.41
2013-12-19	2013-12-17	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	P - Purchase	1,425,063	1,425,063		7.00	9,975,441	9,975,441
2013-11-25	2013-11-22	4	OXFD	Oxford Immunotec Global PLC Series G Preferred Ordinary Shares	C - Conversion	-203,439	0	-100.00
2013-11-25	2013-11-22	4	OXFD	Oxford Immunotec Global PLC Series F Preferred Ordinary Shares	C - Conversion	-553,859	0	-100.00
2013-11-25	2013-11-22	4	OXFD	Oxford Immunotec Global PLC Series E Preferred Ordinary Shares	C - Conversion	-1,239,308	0	-100.00
2013-11-25	2013-11-22	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	C - Conversion	-582,456	0	-100.00
2013-11-25	2013-11-22	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	C - Conversion	203,439	2,579,062	8.56
2013-11-25	2013-11-22	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	C - Conversion	553,859	2,375,623	30.40
2013-11-25	2013-11-22	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	C - Conversion	1,239,308	1,821,764	212.77
2013-11-25	2013-11-22	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	C - Conversion	582,456	582,456
2013-10-28	2013-10-25	4	AERI	AERIE PHARMACEUTICALS INC Convertible Notes	C - Conversion	-420,222	0	-100.00
2013-10-28	2013-10-25	4	AERI	AERIE PHARMACEUTICALS INC Series B Warrants	C - Conversion	-184,812	0	-100.00
2013-10-28	2013-10-25	4	AERI	AERIE PHARMACEUTICALS INC Series B Convertible Preferred Stock	C - Conversion	-2,727,272	0	-100.00
2013-10-28	2013-10-25	4	AERI	AERIE PHARMACEUTICALS INC Common Stock	P - Purchase	321,000	3,653,306	9.63	10.00	3,210,000	36,533,060
2013-10-28	2013-10-25	4	AERI	AERIE PHARMACEUTICALS INC Common Stock	C - Conversion	184,812	3,332,306	5.87	0.05	9,241	166,615
2013-10-28	2013-10-25	4	AERI	AERIE PHARMACEUTICALS INC Common Stock	C - Conversion	420,222	3,147,494	15.41
2013-10-28	2013-10-25	4	AERI	AERIE PHARMACEUTICALS INC Common Stock	C - Conversion	2,727,272	2,727,272
2013-10-02	2013-09-30	4	OPHT	Ophthotech Corp. Series C Preferred Stock	C - Conversion	-186,027	0	-100.00
2013-10-02	2013-09-30	4	OPHT	Ophthotech Corp. Series B Preferred Stock	C - Conversion	-2,542,373	0	-100.00
2013-10-02	2013-09-30	4	OPHT	Ophthotech Corp. Common Stock	C - Conversion	186,027	2,728,390	7.32
2013-10-02	2013-09-30	4	OPHT	Ophthotech Corp. Common Stock	C - Conversion	2,542,373	2,542,373
2013-09-04	2013-09-03	4	GMED	GLOBUS MEDICAL INC Class A Common Stock	J - Other	-7,244,201	0	-100.00
2012-08-10	2012-08-08	4	GMED	GLOBUS MEDICAL INC Series E Preferred Stock	C - Conversion	-7,444,168	0	-100.00
2012-08-10	2012-08-08	4	GMED	GLOBUS MEDICAL INC Class A Common Stock	S - Sale	-804,232	7,244,201	-9.99	11.16	-8,975,229	80,845,283
2012-08-10	2012-08-08	4	GMED	GLOBUS MEDICAL INC Class A Common Stock	C - Conversion	7,444,168	8,048,433	1,231.94
2012-08-02		3	GMED	GLOBUS MEDICAL INC Class A Common Stock			604,265
2012-06-06	2012-06-04	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock	J - Other	22,078	22,078
2012-06-06	2012-06-04	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock	J - Other	51,515	51,515
2012-06-04	2012-05-31	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock Warrant (right to buy)	X - Other	-1,290,922	0	-100.00
2012-06-04	2012-05-31	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock Warrant (right to buy)	X - Other	-1,706,426	0	-100.00
2012-06-04	2012-05-31	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock	S - Sale	-708,810	10,942,471	-6.08	7.49	-5,311,255	81,994,124
2012-06-04	2012-05-31	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock	S - Sale	-608,146	11,651,281	-4.96	7.49	-4,556,960	87,305,379
2012-06-04	2012-05-31	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock	X - Other	1,706,426	12,259,427	16.17	3.11	5,311,251	38,157,467
2012-06-04	2012-05-31	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock	X - Other	1,290,922	10,553,001	13.94	3.53	4,556,955	37,252,094
2011-09-20	2011-09-16	4	ZGNX	ZOGENIX, INC. Common Stock	P - Purchase	3,500,000	9,482,439	58.50	2.00	7,000,000	18,964,878
2010-12-07	2010-12-03	4	AVNR	AVANIR PHARMACEUTICALS, INC. Common Stock	J - Other	-6,669,204	12	-100.00
2010-11-10	2010-11-09	4	AVNR	AVANIR PHARMACEUTICALS, INC. Common Stock	S - Sale	-1,200,000	6,669,216	-15.25	4.81	-5,773,920	32,089,600
2010-11-10	2010-11-08	4	AVNR	AVANIR PHARMACEUTICALS, INC. Common Stock	S - Sale	-44,626	7,869,216	-0.56	5.10	-227,593	40,133,002
2010-11-05	2010-11-05	4	AVNR	AVANIR PHARMACEUTICALS, INC. Common Stock	S - Sale	-332,572	7,913,842	-4.03	4.80	-1,597,377	38,010,975
2010-11-05	2010-11-03	4	AVNR	AVANIR PHARMACEUTICALS, INC. Common Stock	S - Sale	-1,400,106	8,246,414	-14.51	4.52	-6,332,539	37,297,706
2010-11-02	2010-11-02	4	AVNR	AVANIR PHARMACEUTICALS, INC. Common Stock	S - Sale	-1,290,871	9,646,520	-11.80	4.49	-5,800,400	43,345,673
2010-11-02	2010-11-01	4	AVNR	AVANIR PHARMACEUTICALS, INC. Common Stock	S - Sale	-2,478,142	10,937,391	-18.47	5.36	-13,273,424	58,582,854
2010-11-02	2010-10-29	4	AVNR	AVANIR PHARMACEUTICALS, INC. Common Stock	S - Sale	-1,424,947	13,415,533	-9.60	5.06	-7,215,647	67,933,576
2010-10-12	2010-10-11	4	AVNR	AVANIR PHARMACEUTICALS, INC. Common Stock	S - Sale	-311,000	14,840,480	-2.05	3.52	-1,093,445	52,177,644
2010-10-12	2010-10-08	4	AVNR	AVANIR PHARMACEUTICALS, INC. Common Stock	S - Sale	-240,838	15,151,480	-1.56	3.47	-836,792	52,643,817
2010-07-15	2010-07-13	4	AVNR	AVANIR PHARMACEUTICALS, INC. Common Stock	S - Sale	-165,000	15,392,318	-1.06	3.53	-583,143	54,399,530
2008-04-11		3	AVNR	AVANIR PHARMACEUTICALS Class A Common Stock			15,557,318